BCL2L11 and acute lymphoblastic leukemia: Treatment of B-ALL cells with inhibitors of this axis resulted in increased Dex sensitivity through ROS accumulation, decreased O2 consumption, Δψm collapse, cytochrome c release, caspase-3 activation, and BIM release.